<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.eurjchem.com/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-05-10T06:42:07Z</responseDate>
	<request identifier="oai:ojs.www.eurjchem.com:article/319" metadataPrefix="oai_dc" verb="GetRecord">https://www.eurjchem.com/index.php/eurjchem/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:ojs.www.eurjchem.com:article/319</identifier>
				<datestamp>2011-09-30T03:44:50Z</datestamp>
				<setSpec>eurjchem:ART</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Synthesis and antitumor activity of novel pyrazolo[1,5-a]pyrimidine derivatives</dc:title>
	<dc:creator>El-Enany, Mervat Mostafa</dc:creator>
	<dc:creator>Kamel, Mona Monir</dc:creator>
	<dc:creator>Khalil, Omneya Mahmoud</dc:creator>
	<dc:creator>El-Nassan, Hala Bakr</dc:creator>
	<dc:subject xml:lang="en-US">Pyrazole</dc:subject>
	<dc:subject xml:lang="en-US">5-Aminopyrazole</dc:subject>
	<dc:subject xml:lang="en-US">Pyrazolo[1</dc:subject>
	<dc:subject xml:lang="en-US">5‐a]pyrimidine</dc:subject>
	<dc:subject xml:lang="en-US">Antitumor activity</dc:subject>
	<dc:subject xml:lang="en-US">Cytotoxic activity</dc:subject>
	<dc:subject xml:lang="en-US">HCT116</dc:subject>
	<dc:description xml:lang="en-US">A novel series of pyrazolo[1,5-a]pyrimidine-3-carbonitriles substituted with 7-amino, 7-substituted amino and 5-substituted amino groups was synthesized. Some of the newly synthesized compounds were tested in vitro on human colon tumor cell line (HCT116). Compound 14a displayed the highest activity among the tested compounds with IC50 that equals to 0.0020 μM.</dc:description>
	<dc:publisher xml:lang="en-US">Atlanta Publishing House LLC</dc:publisher>
	<dc:date>2011-09-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://www.eurjchem.com/index.php/eurjchem/article/view/319</dc:identifier>
	<dc:identifier>10.5155/eurjchem.2.3.331-336.319</dc:identifier>
	<dc:source xml:lang="en-US">European Journal of Chemistry; Vol. 2 No. 3 (2011): September 2011; 331-336</dc:source>
	<dc:source>2153-2257</dc:source>
	<dc:source>2153-2249</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/319/PDF</dc:relation>
</oai_dc:dc>
			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
